Preinvasive adenocarcinoma lesion of the lung
Updates to Article Attributes
Preinvasive lesions for lung adenocarcinoma are a typecategory of small noninvasive lung lesion which are closely related to adenocarcinoma of the lung. They may represent a spectrum of premalignant andto low-grade malignant lesions.
The category includes two types of lesions:
- atypical adenomatous hyperplasia (AAH) - smaller, mild-moderate cellular atypia, without evidence of invasion
-
adenocarcinoma in situ (AIS) - larger and with more atypia, although
nostill without evidence of invasion
Terminology
In 2011, the International Association for the Study of Lung Cancer (IASLC), American Thoracic Society (ATS), and European Respiratory Society (ERS) introduced a new classification and terminology for adenocarcinoma of the lung. In addition to retiring the term "bronchoalveolar carcinoma (BAC)", the 2011 update officially recognized "adenocarinoma in situ" as a distinct entity with excellent clinical prognosis.
Given its relatively recent recognition, adenocarcinoma in situ remains somewhat controversial and is variable regarded as a low-grade malignancy.
Pathology
Atypical adenomatous hyperplasia and adenocarcinoma in situ may be considered a spectrum of premalignant disease, where atypical adenomatous hyperplasia is typically a small (<5≤5 mm) lesion with mild-moderate cellular atypia, while adenocarcinoma in situ lesions are larger, butyet still ≤3 cm and without evidence ofdemonstrating purely lepidic growth (no invasion). Indeed, intermediate cases may be difficult to distinguish 1.
Findings which indicate more advancedprofound genetic alteration, such as non-lepidic (e.g. papillary) growth patterns or tumor necrosis, indicateindicatemore advanced grade of disease.
Radiographic features
Preinvasive lesions of adenocarcinoma are generally not evident by x-ray.
On CT, both atypical adenomatous hyperplasia and adenocarcinoma in situ typically manifest as a higherround, purely ground glass opacity.
-
usually a single opacity 2
- multiple lesions more common with AIS 2
-
"clear" periphery (>85%) 2
- lobuation, spiculation, pleural indentation are seen in both AAH and AIS, but less common (<21%)
-
vacuole sign - internal gas-appearing lucency <5 mm
- specific to AIS in one 2017 radiology/pathology correlative study (n=80 lesions) 2
-<p><strong>Preinvasive lesions for lung adenocarcinoma</strong> are a type of small noninvasive lung lesion which are closely related to adenocarcinoma of the lung. They may represent a spectrum of premalignant and low-grade malignant lesions.</p><p>The category includes two types of lesions:</p><ul>- +<p><strong>Preinvasive lesions for lung adenocarcinoma</strong> are a category of small noninvasive lung lesion which are closely related to <a href="/articles/adenocarcinoma-of-the-lung">adenocarcinoma of the lung</a>. They may represent a spectrum of premalignant to low-grade malignant lesions.</p><p>The category includes two types of lesions:</p><ul>
-<a title="Atypical adenomatous hyperplasia (AAH)" href="/articles/atypical-adenomatous-hyperplasia-of-the-lung">atypical adenomatous hyperplasia (AAH)</a> - smaller, mild-moderate cellular atypia</li>- +<a href="/articles/atypical-adenomatous-hyperplasia-of-the-lung">atypical adenomatous hyperplasia (AAH)</a> - smaller, mild-moderate cellular atypia, without evidence of invasion</li>
-<a title="Adenocarcinoma in situ (AIS) of lung" href="/articles/adenocarcinoma-in-situ-of-the-lung">adenocarcinoma in situ (AIS)</a> - larger and with more atypia, although no evidence of invasion</li>-</ul><h4>Terminology</h4><p>In 2011, the International Association for the Study of Lung Cancer (IASLC), American Thoracic Society (ATS), and European Respiratory Society (ERS) introduced a new classification and terminology for adenocarcinoma of the lung. In addition to retiring the term "bronchoalveolar carcinoma (BAC)", the 2011 update officially recognized "adenocarinoma in situ" as a distinct entity with excellent clinical prognosis. </p><p>Given its relatively recent recognition, adenocarcinoma in situ remains somewhat controversial and is variable regarded as a low-grade malignancy.</p><h4>Pathology</h4><p>Atypical adenomatous hyperplasia and adenocarcinoma in situ may be considered a spectrum of premalignant disease, where atypical adenomatous hyperplasia is typically a small (<5 mm) lesion with mild-moderate cellular atypia, while adenocarcinoma in situ lesions are larger, but still ≤3 cm and without evidence of invasion. Indeed, intermediate cases may be difficult to distinguish <sup>1</sup>.</p><p>Findings which indicate more advanced genetic alteration, such as non-lepidic (e.g. papillary) growth patterns or tumor necrosis, indicate a higher</p>- +<a href="/articles/adenocarcinoma-in-situ-of-the-lung">adenocarcinoma in situ (AIS)</a> - larger and with more atypia, although still without evidence of invasion</li>
- +</ul><h4>Terminology</h4><p>In 2011, the International Association for the Study of Lung Cancer, American Thoracic Society, and European Respiratory Society introduced a new classification and terminology for adenocarcinoma of the lung. In addition to retiring the term "bronchoalveolar carcinoma (BAC)", the 2011 update officially recognized "adenocarinoma in situ" as a distinct entity with excellent clinical prognosis.</p><h4>Pathology</h4><p>Atypical adenomatous hyperplasia and adenocarcinoma in situ may be considered a spectrum of premalignant disease, where atypical adenomatous hyperplasia is typically a small (≤5 mm) lesion with mild-moderate cellular atypia, while adenocarcinoma in situ lesions are larger, yet still ≤3 cm and demonstrating purely lepidic growth (no invasion). Indeed, intermediate cases may be difficult to distinguish <sup>1</sup>.</p><p>Findings which indicate more profound genetic alteration, such as non-lepidic (e.g. papillary) growth patterns or tumor necrosis, indicatemore advanced grade of disease.</p><h4>Radiographic features</h4><p>Preinvasive lesions of adenocarcinoma are generally not evident by x-ray.</p><p>On CT, both atypical adenomatous hyperplasia and adenocarcinoma in situ typically manifest as a round, purely ground glass opacity.</p><ul>
- +<li>usually a single opacity <sup>2</sup><ul><li>multiple lesions more common with AIS <sup>2</sup>
- +</li></ul>
- +</li>
- +<li>"clear" periphery (>85%) <sup>2</sup><ul><li>lobuation, spiculation, pleural indentation are seen in both AAH and AIS, but less common (<21%)</li></ul>
- +</li>
- +<li>vacuole sign - internal gas-appearing lucency <5 mm<ul><li>specific to AIS in one 2017 radiology/pathology correlative study (n=80 lesions) <sup>2</sup>
- +</li></ul>
- +</li>
- +</ul>
References changed:
- 1. Travis WD, Brambilla E, Noguchi M et-al. International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol. 2011;6 (2): 244-85. <a href="http://dx.doi.org/10.1097/JTO.0b013e318206a221">doi:10.1097/JTO.0b013e318206a221</a> - <a href="http://www.ncbi.nlm.nih.gov/pubmed/21252716">Pubmed citation</a><span class="ref_v3"></span>
- 2. Pan X, Yang X, Li J, Dong X, He J, Guan Y. Is a 5-mm diameter an appropriate cut-off value for the diagnosis of atypical adenomatous hyperplasia and adenocarcinoma in situ on chest computed tomography and pathological examination?. (2018) Journal of thoracic disease. 10 (Suppl 7): S790-S796. <a href="https://doi.org/10.21037/jtd.2017.12.124">doi:10.21037/jtd.2017.12.124</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/29780625">Pubmed</a> <span class="ref_v4"></span>
Tags changed:
- cases
- refs
Sections changed:
- Classifications
Systems changed:
- Chest
- Oncology